Rheumatoid arthritis is increasingly recognized as a significant, and often underappreciated, driver of cardiovascular risk. In this clinician-to-clinician discussion, Amin Yehya, MD shares practical insights on identifying elevated cardiovascular risk in patients with rheumatoid arthritis, understanding the role of chronic inflammation, and applying a more proactive preventive cardiology approach. Designed for primary care providers, rheumatologists, and cardiovascular specialists, this discussion highlights opportunities for earlier intervention and coordinated care.
Hello, everyone. I'm Doctor Aina. I'm a heart failure cardiologist at Centera Heart Hospital. I'll be talking to you today about the increased risk of cardiovascular disease in patients with rheumatoid arthritis. Rheumatoid arthritis is not just a joint disease, it's a systemic inflammatory condition that accelerates atherosclerosis. Patients with RA have an increased risk, up to 70% of cardiovascular disease, comparable in some cases to patients with diabetes. For clinicians, that means that these patients should be viewed as high risk, even when traditional risk factors appear to be controlled. Chronic inflammation is a key driver. It leads to endothelial dysfunction, plaque instability, and accelerated atherosclerosis. At the same time, traditional risk factors such as hypertension, dyslipidemia, diabetes, and smoking can often present and behave differently in RA patients, sometimes masking the true risk. Not entirely. Traditional risk calculators tend to underestimate cardiovascular risk in patients with rheumatoid arthritis, because they don't account for the systemic inflammation that is associated with this disease. That's why guidelines suggest adjusting risk upward or taking a more aggressive approach in these patients. Beyond traditional risk factors for coronary artery disease, clinicians should pay close attention to the high RA disease activity, the elevated inflammatory markers such as CRP and ESR, and the lung disease duration or seropositivity. These RA specific factors are strongly associated with increased risk for cardiovascular events. It requires a dual approach, aggressive control of inflammation through appropriate RA management, and 2 is early and proactive cardiovascular prevention, such as managing diabetes, hypertension, dyslipidemia, and also smoking cessation. Optimal outcomes come from coordinated care between rheumatology, cardiology, and primary care. It is critical to have this coordinated role between different subspecialties, because cardiovascular risk in RA is often under-recognized and undermanaged when care is siloed. A coordinated model ensures patients receive both disease control and preventative cardiology care, which is critical to improving long-term outcomes in this patient population. If there's one thing patients need to remember, is that rheumatoid arthritis patients are at increased risk for cardiovascular disease, so early recognition and proactive management can significantly reduce morbidity and mortality in this patient population.
BROADCASTMED